FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W18392335> ?p ?o ?g. }

• W18392335 endingPage "1891" @default.
• W18392335 startingPage "1881" @default.
• W18392335 abstract "Part of the soluble cyclic nucleotide phosphodiesterase activity of crude human lung tissue can be attributed to a thermosensitive (37 degrees) enzyme with a high apparent affinity for both adenosine 3':5'-monophosphate (cyclic AMP) and guanosine 3':5'-monophosphate (cyclic GMP). The enzyme can be partially purified by DEAE-Sephadex chromatography. In the presence of 0.1 mM EDTA or ethylene glycol bis(beta-aminoethyl ether)N,N'-tetraacetic acid (EGTA), it is eluted from the column immediately before a cyclic GMP-specific phosphodiesterase, but in the presence of 0.2 mM Ca2+, the elution follows that of the cyclic GMP-specific enzyme. The two forms of the nonspecific phosphodiesterase activity are referred to as DEAD-Sephadex Fractions Ia and Ic, respectively. Their apparent molecular weights, recorded at gel filtration, vary with different preparations from 230,000 to 150,000. Occasionally, corresponding recordings for main peaks of activity also cluster round the values 120,000, 105,000, and 78,000. The enzymatic properties of Fractions Ia and Ic closely resemble each other. The enzyme activity is blocked by EDTA, partially inhibited in the presence of 1,10-phenanthroline, but only slightly affected by EGTA. The inhibitory effect of EDTA can be overcome by Mg2+ and Mn2+ and that of 1,10-phenanthroline, in part, by Zn2+; this cation in itself is inhibitory at millimolar concentrations. With submicromolar substrate concentrations, the activity of either fraction obeys linear kinetics displaying an apparent Km of approximately 0.4 micron for both substrates. Reciprocal inhibition experiments suggest that hydrolysis of both cyclic AMP and cyclic GMP is performed by the same active site. Examination of the activity using extended substrate concentration ranges indicates nonlinear kinetics; Hill plots of such data also show nonlinear curvature. The activity is inhibited by micromolar concentrations of inosine 3':5'-monophosphate (cyclic IMP), 3-isobutyl-1-methylxanthine, papervine, and some antiallergic agents. Theophylline and disodium cromoglycate are less potent inhibitors. Inhibition of activity by Lubrol PX follows a biphasic dose response curve. The activity of Fraction Ia can be enhanced 2- to 3-fold by a Ca2+-dependent activator prepared from lung tissue, whose action is counteracted by chlorpromazine, and by lysophosphatidylcholine. It is initially enhanced but subsequently decreased at exposure to trypsin. Fraction Ic is less prone to activation by these agents. The results indicate that the present activity represents an enzyme form that differs from three previously described phosphodiesterases of human lung tissue. It is apparently related to, but also shows distinct differences from the Ca2+-dependent enzyme(s) of brain and heart tissue." @default.
• W18392335 created "2016-06-24" @default.
• W18392335 creator A5008633069 @default.
• W18392335 creator A5052054829 @default.
• W18392335 creator A5073023079 @default.
• W18392335 date "1978-03-01" @default.
• W18392335 modified "2023-09-27" @default.
• W18392335 title "Cyclic nucleotide phosphodiesterase. Partial purification and characterization of a high affinity enzyme activity from human lung tissue." @default.
• W18392335 cites W1495995690 @default.
• W18392335 cites W1499447972 @default.
• W18392335 cites W1505846226 @default.
• W18392335 cites W1505892934 @default.
• W18392335 cites W1554038443 @default.
• W18392335 cites W1574870728 @default.
• W18392335 cites W1575093118 @default.
• W18392335 cites W1581755693 @default.
• W18392335 cites W1589645365 @default.
• W18392335 cites W1595406949 @default.
• W18392335 cites W1599390139 @default.
• W18392335 cites W1607019546 @default.
• W18392335 cites W168583190 @default.
• W18392335 cites W1775749144 @default.
• W18392335 cites W1969125244 @default.
• W18392335 cites W1974860814 @default.
• W18392335 cites W1979165650 @default.
• W18392335 cites W1980678108 @default.
• W18392335 cites W1992383744 @default.
• W18392335 cites W1994894642 @default.
• W18392335 cites W2000677165 @default.
• W18392335 cites W2000787730 @default.
• W18392335 cites W2026288575 @default.
• W18392335 cites W2031462923 @default.
• W18392335 cites W2033860498 @default.
• W18392335 cites W2043228367 @default.
• W18392335 cites W2047404335 @default.
• W18392335 cites W2051553799 @default.
• W18392335 cites W2056889378 @default.
• W18392335 cites W2056987277 @default.
• W18392335 cites W2059107115 @default.
• W18392335 cites W2064987833 @default.
• W18392335 cites W2067443500 @default.
• W18392335 cites W2074054469 @default.
• W18392335 cites W2076552691 @default.
• W18392335 cites W2081330336 @default.
• W18392335 cites W2113506485 @default.
• W18392335 cites W2397861637 @default.
• W18392335 cites W90454921 @default.
• W18392335 doi "https://doi.org/10.1016/s0021-9258(19)62332-x" @default.
• W18392335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/204635" @default.
• W18392335 hasPublicationYear "1978" @default.
• W18392335 type Work @default.
• W18392335 sameAs 18392335 @default.
• W18392335 citedByCount "22" @default.
• W18392335 countsByYear W183923352015 @default.
• W18392335 countsByYear W183923352016 @default.
• W18392335 crossrefType "journal-article" @default.
• W18392335 hasAuthorship W18392335A5008633069 @default.
• W18392335 hasAuthorship W18392335A5052054829 @default.
• W18392335 hasAuthorship W18392335A5073023079 @default.
• W18392335 hasBestOaLocation W183923351 @default.
• W18392335 hasConcept C104317684 @default.
• W18392335 hasConcept C181199279 @default.
• W18392335 hasConcept C185592680 @default.
• W18392335 hasConcept C2780215583 @default.
• W18392335 hasConcept C28212737 @default.
• W18392335 hasConcept C512185932 @default.
• W18392335 hasConcept C55493867 @default.
• W18392335 hasConcept C62826618 @default.
• W18392335 hasConceptScore W18392335C104317684 @default.
• W18392335 hasConceptScore W18392335C181199279 @default.
• W18392335 hasConceptScore W18392335C185592680 @default.
• W18392335 hasConceptScore W18392335C2780215583 @default.
• W18392335 hasConceptScore W18392335C28212737 @default.
• W18392335 hasConceptScore W18392335C512185932 @default.
• W18392335 hasConceptScore W18392335C55493867 @default.
• W18392335 hasConceptScore W18392335C62826618 @default.
• W18392335 hasIssue "6" @default.
• W18392335 hasLocation W183923351 @default.
• W18392335 hasOpenAccess W18392335 @default.
• W18392335 hasPrimaryLocation W183923351 @default.
• W18392335 hasRelatedWork W1980187661 @default.
• W18392335 hasRelatedWork W1980962433 @default.
• W18392335 hasRelatedWork W1996788259 @default.
• W18392335 hasRelatedWork W1998920509 @default.
• W18392335 hasRelatedWork W2044627851 @default.
• W18392335 hasRelatedWork W2050155704 @default.
• W18392335 hasRelatedWork W2052452115 @default.
• W18392335 hasRelatedWork W2319358689 @default.
• W18392335 hasRelatedWork W34019034 @default.
• W18392335 hasRelatedWork W4238681840 @default.
• W18392335 hasVolume "253" @default.
• W18392335 isParatext "false" @default.
• W18392335 isRetracted "false" @default.
• W18392335 magId "18392335" @default.
• W18392335 workType "article" @default.